A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 2794
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : IL-3
Long Form : interleukin-3
No. Year Title Co-occurring Abbreviation
2020 Acid Stripping of Surface IgE Antibodies Bound to FcepsilonRI is Unsuitable for the Functional Assays that Require Long-Term Culture of Basophils and Entire Removal of Surface IgE. IgE
2020 Assessment of faithful interleukin-3 production by novel bicistronic interleukin-3 reporter mice. ---
2020 Deficiency of core fucosylation activates cellular signaling dependent on FLT3 expression in a Ba/F3 cell system. AML, FLT3, ITD, KO, TKD, WT
2020 Interleukin 2 regulates the activation of human basophils. LTC4
2020 Levels of cytokines and GADA in type I and II diabetic patients. GADA, IL-1 beta, INF-gamma
2020 The RNFT2/IL-3Ralpha axis regulates IL-3 signaling and innate immunity. ---
2020 [Effect of Huai Qi Huang on asthma in rats and the mechanism research]. BALF, HQH, IgE, IL-10, IL-4, IL-5, INF-gamma
2019 An unbiased in vitro screen for activating epidermal growth factor receptor mutations. EGFR, iSCREAM, RTK
2019 Biochemical diagnostics of pancreatic cancer - Present and future. CEA, G-CSF, HGFs, M-CSF, PCR
10  2019 Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia. AML, Cas9, CRISPR, LSCs, MLL, sgRNA
11  2019 Enhanced Ex Vivo Generation of Erythroid Cells from Human Induced Pluripotent Stem Cells in a Simplified Cell Culture System with Low Cytokine Support. EPO, HCFC, hiPSCs, RBC, SCF
12  2019 Hematopoietic cytokines mediate resistance to targeted therapy in FLT3-ITD acute myeloid leukemia. AML, FLT3, GM-CSF, PIM
13  2019 In the absence of apoptosis, myeloid cells arrest when deprived of growth factor, but remain viable by consuming extracellular glucose. FBS
14  2019 Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia. AML, CRP, GA, IL-6, IL-6sR, SPPB, TNF-alpha, TNFalpha sR1
15  2019 Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease. anti-CTLA-4, GM-CSF
16  2019 Malignant Transformation of Fanconi Anemia Complementation Group D2-deficient (Fancd2 -/-) Hematopoietic Progenitor Cells by a Single HPV16 Oncogene. HPV, HPV16
17  2019 Protective effects of cytokine combinations against the apoptotic activity of glucocorticoids on CD34+ hematopoietic stem/progenitor cells. GCs, HSPC
18  2019 Radioresistance of Serpinb3a-/- Mice and Derived Hematopoietic and Marrow Stromal Cell Lines. ---
19  2019 Rapid generation of gene-targeted EPS-derived mouse models through tetraploid complementation. EPS, ES, IL-6
20  2019 Splenic Innate B1 B Cell Plasmablasts Produce Sustained Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-3 Cytokines during Murine Malaria Infections. GM-CSF, IRA, TLR4
21  2019 Tagraxofusp, a novel CD123-directed cytotoxin to treat blastic plasmacytoid dendritic cell neoplasm. BPDCN, CD123, DT, FDA
22  2019 Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma. GLS1, MM, PCT
23  2019 The inhibitor of interleukin-3 receptor protects against sepsis in a rat model of cecal ligation and puncture. CLP, IL-10, IL-1beta, IL-6, JAK2, MAP, STAT5, TNF-alpha
24  2019 [Isolation,Purification and Differentiation of Hematopoietic Stem Cells into Dendritic Cells in Mouse Lung Tissue]. DC, ELISA, GM-CSF, HSCs, LPS, SCF
25  2018 A dual role for the N-terminal domain of the IL-3 receptor in cell signalling. NTD
26  2018 Characterisation of the porcine cytokines which activate the CD131betac common sub-unit, for potential immune-augmentation. 5-FU, BM, GM-CSF, HSC, IL-5, IM, po, rPo
27  2018 Gain-of-function mutations in granulocyte colony-stimulating factor receptor (CSF3R) reveal distinct mechanisms of CSF3R activation. ---
28  2018 Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice. HHEX, pml
29  2018 IL-3 but not monomeric IgE regulates FcepsilonRI levels and cell survival in primary human basophils. ---
30  2018 IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the beta-catenin pathway. APC, ECs, EV, EVs, GSK3beta, TECs
31  2018 Integrated Biosensor for Rapid and Point-of-Care Sepsis Diagnosis. IBS
32  2018 Interleukin-3 is required for thoracic aneurysm and dissection in a mouse model. MMP12, TAAD
33  2018 Interleukin-3 stimulates matrix metalloproteinase 12 production from macrophages promoting thoracic aortic aneurysm/dissection. JNK, MMPs, SMCs, TAAD
34  2018 Protective Effect of the c-mpl Agonist Romiplostim on Megakaryocytopoiesis of Human CD34+ Hematopoietic Progenitor Cells Exposed to Ionizing Radiation. MPL, RP, SCF, TPO
35  2018 The multiple functions and mechanisms of osteopontin. IFN-gamma, IL-10, IL-12, NF-kB, OPN
36  2018 Unchanged Erythrocyte Profile After Exposure to Cryogenic Temperatures in Elder Marathon Runners. EPO, WBCST
37  2018 Yirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice. AS, IL-1alpha, IL-1beta, IL-27, IL-6, LDL-C, Ox-LDL, RANTES, TG, YR
38  2017 A Chemically Inducible Helper Module for Detecting Protein-Protein Interactions with Tunable Sensitivity Based on KIPPIS. KIPPIS, PPIs
39  2017 A novel agent SL-401 induces anti-myeloma activity by targeting plasmacytoid dendritic cells, osteoclastogenesis and cancer stem-like cells. BM, MM, OCL, pDCs
40  2017 Association between gene polymorphisms and clinical features in idiopathic thrombocytopenic purpura patients. IFN, ITP
41  2017 c-Kit-Positive Adipose Tissue-Derived Mesenchymal Stem Cells Promote the Growth and Angiogenesis of Breast Cancer. ASCs, EPCs
42  2017 Do IL-3/GM-CSF effect on the myofibroblastic differentiation of human adipose derived stromal cells? GFAP, GM-CSF, hASCs
43  2017 Drug-resistance in doxorubicin-resistant FL5.12 hematopoietic cells: elevated MDR1, drug efflux and side-population positive and decreased BCL2-family member expression. CSC
44  2017 Genetically engineered mesenchymal stromal cells produce IL-3 and TPO to further improve human scaffold-based xenograft models. ALL, AML, BAL, BM, CB, MSCs, TPO
45  2017 Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth. CML, IL3-R, IM
46  2017 Interleukin-3 enhances the migration of human mesenchymal stem cells by regulating expression of CXCR4. IL-3Ralpha, MSCs, SDF-1alpha
47  2017 Interleukin-3 Prevents Cellular Death Induced by Oxidative Stress in HEK293 Cells. ---
48  2017 Skin CD4+ Memory T Cells Play an Essential Role in Acquired Anti-Tick Immunity through Interleukin-3-Mediated Basophil Recruitment to Tick-Feeding Sites. ---
49  2017 Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells. ---
50  2017 Thrombopoietin contributes to the formation and the maintenance of hematopoietic progenitor-containing cell clusters in the aorta-gonad-mesonephros region. AGM, SCF, TPO
51  2016 A Phenotypic Screen for Small-Molecule Inhibitors of Constitutively Active Mutant Thrombopoietin Receptor Implicated in Myeloproliferative Neoplasms. EpoR, TpoR
52  2016 A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors. EpoR, VEGFR2
53  2016 Activated Stat5 trafficking Via Endothelial Cell-derived Extracellular Vesicles Controls IL-3 Pro-angiogenic Paracrine Action. ChIP, ECs, EVs
54  2016 Adaptive evolution of interleukin-3 (IL3), a gene associated with brain volume variation in general human populations. EHH
55  2016 Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia. ELISA, FEDN, PANSS
56  2016 Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases. G-CSF, GM-CSF, M-CSF
57  2016 Effect of STAT3 inhibitor in chronic myeloid leukemia associated signaling pathway: a mathematical modeling, simulation and systems biology study. CML, HGF, ODEs
58  2016 Effects and mechanisms of Bazhen decoction, Siwu decoction, and Sijunzi decoction on 5-fluorouracil-induced anemia in mice. 5-FU, BZD, EPO, GM-CSF, IFN-gamma, SJZD, SWD, TNF-alpha
59  2016 Growth signalobody selects functional intrabodies in the mammalian cytoplasm. RTK, RV-P, scFv
60  2016 Hematopoietic Effects of Paeoniflorin and Albiflorin on Radiotherapy-Induced Myelosuppression Mice. AF, GM-CSF, PF, TCM, TNF-alpha, WBC
61  2016 Improved Survival and Hematopoietic Differentiation of Murine Embryonic Stem Cells on Electrospun Polycaprolactone Nanofiber. EBs, ECM, FBS, hESCs, LIF, mESCs, mHSCs, PCL, RPMI-1640, SCF
62  2016 Interleukin-3 receptor alpha chain (CD123) is preferentially expressed in immature T-ALL and may not associate with outcomes of chemotherapy. AML, B-ALL, MRD, T-ALL
63  2016 Internal tandem duplication and tyrosine kinase domain mutations in FLT3 alter the response to daunorubicin in Ba/F3 cells. FLT3, FLT3, ITD, TKD
64  2016 Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective. BBG, IOP, P2X7Rs, RGCs
65  2016 Protective effects of paeoniflorin and albiflorin on chemotherapy-induced myelosuppression in mice. AF, ELISA, GM-CSF, i.p, IL-6, PF, RIA, TCM, TNF-alpha, WBC
66  2016 Rutin Attenuates Hepatotoxicity in High-Cholesterol-Diet-Fed Rats. Bbc3, HCD, IL-6, TGF-beta
67  2016 Treatment of blastic plasmacytoid dendritic cell neoplasm. BPDCN
68  2016 [Biological characteristics of mesenchymal stem cell and hematopoietic stem cell in the co-culture system]. Flt3L, MSC, SCF, TPO
69  2015 A Phase 1 study of the safety, pharmacokinetics and anti-leukemic activity of the anti-CD123 monoclonal antibody CSL360 in relapsed, refractory or high-risk acute myeloid leukemia. AML, AUC, IgG1, MoAb
70  2015 AntiCD3Fv fused to human interleukin-3 deletion variant redirected T cells against human acute myeloid leukemic stem cells. AML, ds, LSCs, NOD/SCID
71  2015 Association of interleukin 3 (IL-3) polymorphisms with schizophrenia in Han Chinese population. ---
72  2015 CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice. APOE, EPCs
73  2015 Dominant-negative IKAROS enhances IL-3-stimulated signaling in wild-type but not BCR-ABL1(+) mouse BA/F3 cells. ---
74  2015 High sensitivity automated multiplexed immunoassays using photonic crystal enhanced fluorescence microfluidic system. Cy5, PCEF
75  2015 Identification of mutant alleles of JAK3 in pediatric patients with acute lymphoblastic leukemia. ALL, JAK/STAT
76  2015 Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. ---
77  2015 Interleukin-3 greatly expands non-adherent endothelial forming cells with pro-angiogenic properties. ECs, EPCs, EXnaEFCs
78  2015 Large-scale hematopoietic differentiation of human induced pluripotent stem cells provides granulocytes or macrophages for cell replacement therapies. G-CSF, M-CSF
79  2015 MicroRNA-29b inhibits migration and proliferation of vascular smooth muscle cells in neointimal formation. miRs, SMCs
80  2015 Pim-2 kinase is an important target of treatment for tumor progression and bone loss in myeloma. MM, TGF-beta
81  2015 The betac receptor family - Structural insights and their functional implications. GM-CSF
82  2015 The importance of the granulocyte-colony stimulating factor in oncology. G-CSF, GM-CSF, IL-5
83  2014 Basophil expansion protects against invasive pneumococcal disease in mice. IPD, PspA
84  2014 Bone resorption is regulated by cell-autonomous negative feedback loop of Stat5-Dusp axis in the osteoclast. cKO, DUSP1, MAPKs, RANKL, STAT5
85  2014 Correlation between Plasma Interleukin-3, the alpha/beta Globin Ratio, and Globin mRNA Stability. GCS
86  2014 Crystal structure of the mouse interleukin-3 beta-receptor: insights into interleukin-3 binding and receptor activation. GM-CSF
87  2014 Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound to the Fab fragment of antibody CSL362. IL3Ralpha, mAb
88  2014 Cytokines as potential biomarkers of liver toxicity induced by Dioscorea bulbifera L. ALT/AST, CD30L, ELISA
89  2014 Dual mechanism of interleukin-3 receptor blockade by an anti-cancer antibody. GM-CSF, IL3Ralpha, NTD
90  2014 Effects of carnosine on cyclophosphamide-induced hematopoietic suppression in mice. CSA, SCF
91  2014 Hematological parameters, and hematopoietic growth factors: EPO and IL-3 in response to whole-body cryostimulation (WBC) in military academy students. EPO, WBC
92  2014 Hematopoietic effects and mechanisms of Fufang e׳jiao jiang on radiotherapy and chemotherapy-induced myelosuppressed mice. BMNC, BMSC, CFU-F, EPO, FEJ, GM-CSF, HSC, IL-6, RT-qPCR, TGF-beta, TNF-alpha
93  2014 Interleukin-3-deficient mice have increased resistance to blood-stage malaria. G-CSF, KO, MIG, WT
94  2014 Introduction of mismatches in a random shRNA-encoding library improves potency for phenotypic selection. RNAi, shRNA
95  2014 Monoclonal antibody targeting of IL-3 receptor alpha with CSL362 effectively depletes CML progenitor and stem cells. ADCC, CML, LSPCs, NK, TKIs
96  2014 The haematopoietic effect of Panax japonicus on blood deficiency model mice. APH, CSF, EPO, Hgb, HGFs, IL-6, RBC, WBC
97  2014 The role of HuR in the post-transcriptional regulation of interleukin-3 in T cells. 3'-UTRs, ARE, ARE-BPs, EMSAs
98  2014 Tracing the origin of the HSC hierarchy reveals an SCF-dependent, IL-3-independent CD43(-) embryonic precursor. AGM, HSCs, SCF
99  2014 Unexpected mechanisms of action for a cytokine receptor-blocking antibody. ---
100  2013 A high-fat diet increases interleukin-3 and granulocyte colony-stimulating factor production by bone marrow cells and triggers bone marrow hyperplasia and neutrophilia in Wistar rats. CON, G-CSF, GM-CSF, HFD